Overview

Voclosporin in Adolescents With Lupus Nephritis

Status:
Not yet recruiting

Trial end date:
2025-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of voclosporin compared to placebo in achieving renal response following 24 weeks of therapy in adolescents with active lupus nephritis (LN).

Phase:

Phase 3

Details

Lead Sponsor:

Aurinia Pharmaceuticals Inc.

Collaborator:

Labcorp Drug Development, Inc.